Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._1 type RangedSequencePosition NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY.assertion.
- NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._1 type SO_0001148 NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY.assertion.
- NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._1 comment "Inactivates bleomycin B2 (a cytotoxic glycometallopeptide) by hydrolysis of a carboxyamide bond of beta-aminoalanine, but also shows general aminopeptidase activity. The specificity varies somewhat with source, but amino acid arylamides of Met, Leu and Ala are preferred." NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY.assertion.
- NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._1 SIO_000053 NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._2 NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY.assertion.
- NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._1 SIO_000053 NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY._3 NX_Q13867-1_MUTAGEN_NA_NA.RAzGFCYWJXSC_sVx5OO2t3XH_48KQT63UG2gp4YENusUY.assertion.